Head, Division of Pediatric Hematology-Oncology
First Department of Pediatrics, National and Kapodistrian University of Athens,
‘Aghia Sophia’ Children’s Hospital
Papadiamantopoulou and Levadias, Goudi 11527, Athens, Greece
First Department of Pediatrics, National and Kapodistrian University of Athens, Greece.
Antonis Kattamis is Professor of Pediatric Hematology–Oncology at the National and Kapodistrian University of Athens. He received his MD degree (cum laude) in 1988 from the National and Kapodistrian University of Athens. He completed his training in Pediatrics at the University of Texas Health Science Center in San Antonio, USA and in Pediatric Hematology–Oncology at the Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, USA.
Prof Kattamis is the Head of the Division of Hematology-Oncology of the First Department of Pediatrics, National and Kapodistrian University of Athens, “Aghia Sofia” Children’s Hospital, Athens, Greece. The Oncology Unit, which is part of the Division, is the largest pediatric oncology unit in Greece, taking care around 30% of all the pediatric and adolescent patients with neoplastic diseases that are diagnosed in Greece on annual basis. The Hematology Unit/Thalassemia Unit, which is part of the division, is the largest one in Greece where more than 500 patients with Thalassemia and other congenital anemias are followed.
Prof Kattamis has participated in many consulting committees, like the Ministry Counseling Board on Thalassemia, and council boards, like the ones of the Athens Comprehensive Cancer Center, the European Society of Pediatric Hematology Immunology and the Hellenic Society of Pediatric Hematlogy-Oncology, of which he is the elected President (2018-20) and the European Hematology Association Annual Conference Advisory Board (2019-2020).
He has published more than 150 articles in peer-reviewed journals, including NEJM, Blood and Haematologica, mainly in the field of hemoglobinopathies, iron metabolism and pediatric hematology-oncology. He has given many lectures around the world in national and international meetings, including ASH, ΕΗΑ and the Thalassemia International Federation. He has participated in numerous clinical trials and collaborative research programs, funded by the European Union (FP7), the University and Pharmaceutical companies. He has served in the Steering Committees in pivotal clinical studies, mainly on the field of hemoglobinopathies. He has participated in SIOP-E and iBFM oncology protocols and is the National Coordinator for SIOPE-BT neuro-oncology studies.